@US_FDA Given #molnupiravir's usage to treat #COVID19 is inevitable, what can be done to prevent the potential acceleration of #SARSCoV2 variants?
1⃣patients should strictly ISOLATE WHILE TAKING, especially in the first days on the drug
2⃣ALL DOSES should be taken PRECISELY as directed
@US_FDA Our own reasons for these recommendations are presented here 👇
@US_FDA Finally, it seems prudent whenever possible to use other treatment options that do not carry a mutational risk. #Paxlovid (a #ProteaseInhibitor) allegedly has much better efficacy, and other drugs like #masitinib and 4′-FlU are close at hand. 👇
@US_FDA@Merck First, @Merck and the @US_FDA panelists have done excellent work compiling and analyzing the available data. This was not an easy vote (13 YES/10 NO).
However, specifically on the potential for molnupiravir to induce new viral variants, the results only augment my concerns.
2/n
@US_FDA@Merck 1⃣MUTATION VS. SELECTION. The materials repeatedly confuse mutation and selection (e.g., "The Spike protein is already under evolutionary pressure with or without molnupiravir", 3hr).
Contrarily, the concern is this drug is a mutagen and provides RAW MATERIAL, not selection. 3/n
TODAY’S (6月21日) #COVID19 update for #Taiwan 🇹🇼
📉75 local + 0 imported cases 📉trend
📉20 deaths 📈trend
📈0.6% test positive rate
📈4.2% case fatality rate (CFR) since May 1
🧪13k tests ⤵️capacity
⚠️It's Monday. Numbers of tests and their positive rates are key metrics. ⬇️ 1/6
DAILY CASES REPORTED (pink bars) and their 7-DAY AVERAGE (pink line), where each day is the mean of itself and the previous six. DEATHS (crimson red bars) at the bottom. THRILLED to have room for the chart legend specifically in the top right quadrant! 2/6
AGE DISTRIBUTION OF CASES. Local cases from May 1-June 20 (age data for cases lag by a day), including those with missing locations. Only a single category is provided for ages >70, which constitute 14% of all cases. DATA ➡️ data.cdc.gov.tw/en/dataset/ags… 3/6
TODAY’S (6月20日) #COVID19 update for #Taiwan 🇹🇼
📉107 local + 2 imported cases 📉trend
📉11 deaths 📉trend
📈0.6% test positive rate
📈4.1% case fatality rate (CFR) since May 1
🧪20k tests ⤵️capacity
⚠️Fewer cases BUT many fewer tests, higher positivity, and higher CFR. ⬇️ 1/6
DAILY CASES REPORTED (pink bars) and their 7-DAY AVERAGE (pink line), where each day is the mean of itself and the previous six. DEATHS (crimson red bars) at the bottom.
AGE DISTRIBUTION OF DEATHS for May 1-June 20:
🔴64% are ≥70
🔴26% are 60-69
🔴10% are 30-59 years 2/6
AGE DISTRIBUTION OF CASES. Local cases from May 1-June 19 (age data for cases lag by a day), including those with missing locations. Only a single category is provided for ages >70, which constitute 14% of all cases. DATA ➡️ data.cdc.gov.tw/en/dataset/ags… 3/6